Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Convenience stores, supermarkets start selling drugs

TOKYO, Japan - A registered salesman checks nonprescription drugs on a shelf of a pharmacy in a convenience store outlet of Seven-Eleven Japan Co. in Tokyo's Chiyoda Ward on June 1, which began the 24-hour sale of such drugs on a pilot basis. Japanese convenience stores and supermarkets began selling the drugs, some around the clock, on June 1 as deregulation under a revised pharmacy law took effect.

E

Convenience stores, supermarkets start selling drugs

TOKYO, Japan - A female customer checks nonprescription drugs sold at the pharmacy in a convenience store outlet of Seven-Eleven Japan Co. in Tokyo's Chiyoda Ward on June 1, which began the 24-hour sale of such drugs on a pilot basis. Japanese convenience stores and supermarkets began selling nonprescription drugs, some around the clock, on June 1 as deregulation under a revised pharmacy law took effect.

E

Daiichi Sankyo to acquire Zepharma from Astellas

TOKYO, Japan - Takashi Shoda (R), president of Daiichi Sankyo Co., and Masaji Oe, president of Zepharma Inc., stellas Pharma Inc.'s nonprescription drug unit, shake hands at a news conference at Daiichi Sankyo's head office in Tokyo on March 31. They announced Daiichi Sankyo will buy Zepharma for 23.5 billion yen.

E

Daiichi Sankyo to acquire Zepharma from Astellas

TOKYO, Japan - Takashi Shoda (R), president of Daiichi Sankyo Co., and Masaji Oe, president of Zepharma Inc., stellas Pharma Inc.'s nonprescription drug unit, shake hands at a news conference at Daiichi Sankyo's head office in Tokyo on March 31. They announced Daiichi Sankyo will buy Zepharma for 23.5 billion yen. (Kyodo)

E

Convenience stores, supermarkets start selling drugs

TOKYO, Japan - A registered salesman checks nonprescription drugs on a shelf of a pharmacy in a convenience store outlet of Seven-Eleven Japan Co. in Tokyo's Chiyoda Ward on June 1, which began the 24-hour sale of such drugs on a pilot basis. Japanese convenience stores and supermarkets began selling the drugs, some around the clock, on June 1 as deregulation under a revised pharmacy law took effect. (Kyodo)

E

Convenience stores, supermarkets start selling drugs

TOKYO, Japan - A female customer checks nonprescription drugs sold at the pharmacy in a convenience store outlet of Seven-Eleven Japan Co. in Tokyo's Chiyoda Ward on June 1, which began the 24-hour sale of such drugs on a pilot basis. Japanese convenience stores and supermarkets began selling nonprescription drugs, some around the clock, on June 1 as deregulation under a revised pharmacy law took effect. (Kyodo)

E

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

E

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

E

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

E

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows the global headquarters building of Takeda Pharmaceutical Co. The company said the same day it will sell its over-the-counter medicine unit Takeda Consumer Healthcare Co. for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

E

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

E

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows the global headquarters building of Takeda Pharmaceutical Co. The company said the same day it will sell its over-the-counter medicine unit Takeda Consumer Healthcare Co. for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

E

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

E

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.